Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites, restore prot⦠read more
Healthcare
Biotechnology
2 years
USD
Exclusive to Premium users
$1.78
Price+0.57%
$0.01
$63.989m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$82.240k
-
1y CAGR-
3y CAGR-
5y CAGR-$18.593m
-
1y CAGR-
3y CAGR-
5y CAGR-$0.66
-
1y CAGR-
3y CAGR-
5y CAGR$3.696m
$9.834m
Assets$6.138m
Liabilities$229.170k
Debt2.3%
-
Debt to EBITDA-$9.532m
-
1y CAGR-
3y CAGR-
5y CAGR